Position in FULC
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$2,495,505
+$1,319,357 QoQ
Shares Held
681,832
+344.6% QoQ
Ownership
0.894%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#33
of 154 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $205,108,253 across 117 Biotechnology names. FULC ranks #33 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
101,908 | $10,865,430 | |
| 2 | MRNA |
Moderna, Inc.
|
139,861 | $9,794,465 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
107,419 | $8,000,567 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
22,923 | $5,610,862 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
67,374 | $5,342,084 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
573,581 | $4,800,872 | |
| 7 | UPB |
Upstream Bio, Inc.
|
693,555 | $4,799,400 | |
| 8 | NRIX |
Nurix Therapeutics, Inc.
|
192,434 | $4,668,448 |
All Filings in FULC
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,495,505 | 681,832 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,176,148 | 153,344 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $754,557 | 66,716 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $103,702 | 11,272 | Shares | Sole | 2025-10-31 | |
| 2025-03-31 | $92,407 | 32,086 | Shares | Sole | 2025-05-06 | |
| 2024-09-30 | $253,837 | 71,103 | Shares | Sole | 2024-11-15 | |
| 2024-03-31 | $513,687 | 54,416 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $110,821 | 16,418 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $203,237 | 61,587 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $84,539 | 29,663 | Shares | Sole | 2023-05-09 | |
| No filing history on record for this holder in this stock. | ||||||